Patent Term Application for ATTRUBY™ (acoramidis), Patent No. 10,398,681 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0359

Patent Term Application for ATTRUBY™ (acoramidis), Patent No. 10,398,681

Documents

Comments

Description

OPEN

Comment Period OpensFeb 4, 2025

Comment Period ClosesApr 15, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; ATTRUBY FR Doc: 2026-02971	Feb 13, 2026	--

CDER

Patent Term Application for ATTRUBY (acoramidis)

The Board of Trustees of the

Leland Stanford Junior University

Edward J. Baba

Patent No. 10,398,681

OPEN